Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial

Thomas A. Zelniker,Maddalena Ardissino,Felicita Andreotti,Michelle L. O'Donoghue,Ophelia Yin,Jeong-Gun Park,Sabina A. Murphy,Christian T. Ruff,Hans Lanz,Elliott M. Antman,Eugene Braunwald,Robert P. Giugliano,Piera Angelica Merlini

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial

2021

Thomas A. Zelniker
Maddalena Ardissino
Felicita Andreotti
Michelle L. O'Donoghue
Ophelia Yin
Jeong-Gun Park
Sabina A. Murphy
Christian T. Ruff
Hans Lanz
Elliott M. Antman
Eugene Braunwald
Robert P. Giugliano
Piera Angelica Merlini

Background: Female sex is an independent risk factor for stroke and systemic embolic events in patients with atrial fibrillation. This study aimed to examine the efficacy and safety profile of edox...

Keywords:

Warfarin
Atrial fibrillation
Factor Xa Inhibitor
Edoxaban
Stroke
female sex
Medicine
Risk factor
Cardiology
Internal medicine
TIMI

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations